![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | TAF5L | Human | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TAF5L mRNA | CTD | PMID:24763279 | TAF5L | Human | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of TAF5L mRNA | CTD | PMID:23649840 | TAF5L | Human | 1,2-dimethylhydrazine | increases expression | ISO | Taf5l (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of TAF5L mRNA | CTD | PMID:22206623 | TAF5L | Human | 17alpha-ethynylestradiol | increases expression | ISO | Taf5l (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of TAF5L mRNA | CTD | PMID:17942748 | TAF5L | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Taf5l (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TAF5L mRNA | CTD | PMID:17942748 | TAF5L | Human | 17alpha-ethynylestradiol | affects expression | ISO | Taf5l (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of TAF5L mRNA | CTD | PMID:17555576 | TAF5L | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | EGF protein promotes the reaction [Estradiol results in increased expression of TAF5L mRNA] | CTD | PMID:24758408 | TAF5L | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TAF5L mRNA | CTD | PMID:24758408 | TAF5L | Human | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of TAF5L mRNA | CTD | PMID:29581250 | TAF5L | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases methylation | ISO | Taf5l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased methylation of TAF5L gene | CTD | PMID:21212295 | TAF5L | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Taf5l1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TAF5L mRNA | CTD | PMID:33387578 | TAF5L | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Taf5l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TAF5L mRNA | CTD | PMID:21570461 | TAF5L | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Taf5l (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TAF5L mRNA; [Tetrachlorodibenzodioxin co-treated with more ... | CTD | PMID:17942748|PMID:21212295 | TAF5L | Human | 3,3',5-triiodo-L-thyronine | increases expression | EXP | | 6480464 | Triiodothyronine results in increased expression of TAF5L mRNA | CTD | PMID:23397585 | TAF5L | Human | 5-fluorouracil | multiple interactions | EXP | | 6480464 | [Fluorouracil co-treated with irinotecan] results in decreased expression of TAF5L mRNA | CTD | PMID:16391804 | TAF5L | Human | acrylamide | increases expression | ISO | Taf5l1 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of TAF5L mRNA | CTD | PMID:28959563 | TAF5L | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of TAF5L gene | CTD | PMID:27153756 | TAF5L | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of TAF5L mRNA | CTD | PMID:19774075 | TAF5L | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of TAF5L 5' UTR | CTD | PMID:27901495 | TAF5L | Human | bisphenol A | affects expression | ISO | Taf5l1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of TAF5L mRNA | CTD | PMID:25181051 | TAF5L | Human | bisphenol A | increases expression | ISO | Taf5l1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of TAF5L mRNA | CTD | PMID:30816183|PMID:32528016 | TAF5L | Human | bisphenol A | affects methylation | ISO | Taf5l (Mus musculus) | 6480464 | bisphenol A affects the methylation of TAF5L promoter | CTD | PMID:27334623 | TAF5L | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of TAF5L mRNA | CTD | PMID:26079696 | TAF5L | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of TAF5L mRNA | CTD | PMID:38174414|PMID:38568856 | TAF5L | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of TAF5L mRNA | CTD | PMID:19549813 | TAF5L | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of TAF5L mRNA | CTD | PMID:25562108 | TAF5L | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | TAF5L | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of TAF5L mRNA | CTD | PMID:29803840 | TAF5L | Human | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of TAF5L mRNA | CTD | PMID:19244175 | TAF5L | Human | epoxiconazole | decreases expression | ISO | Taf5l (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of TAF5L mRNA | CTD | PMID:35436446 | TAF5L | Human | ethanol | affects expression | ISO | Taf5l (Mus musculus) | 6480464 | Ethanol affects the expression of TAF5L mRNA | CTD | PMID:30319688 | TAF5L | Human | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of TAF5L mRNA | CTD | PMID:23649840 | TAF5L | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of TAF5L mRNA | CTD | PMID:23649840 | TAF5L | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of TAF5L protein | CTD | PMID:37730182 | TAF5L | Human | irinotecan | multiple interactions | EXP | | 6480464 | [Fluorouracil co-treated with Irinotecan] results in decreased expression of TAF5L mRNA | CTD | PMID:16391804 | TAF5L | Human | ketoconazole | affects expression | EXP | | 6480464 | Ketoconazole affects the expression of TAF5L mRNA | CTD | PMID:36621641 | TAF5L | Human | lipopolysaccharide | multiple interactions | ISO | Taf5l (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of TAF5L gene | CTD | PMID:21212295 | TAF5L | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of TAF5L mRNA | CTD | PMID:23649840 | TAF5L | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of TAF5L mRNA | CTD | PMID:25583101 | TAF5L | Human | okadaic acid | increases expression | EXP | | 6480464 | Okadaic Acid results in increased expression of TAF5L mRNA | CTD | PMID:38832940 | TAF5L | Human | p-toluidine | decreases expression | ISO | Taf5l1 (Rattus norvegicus) | 6480464 | 4-toluidine results in decreased expression of TAF5L mRNA | CTD | PMID:27638505 | TAF5L | Human | paracetamol | affects expression | ISO | Taf5l (Mus musculus) | 6480464 | Acetaminophen affects the expression of TAF5L mRNA | CTD | PMID:17562736 | TAF5L | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of TAF5L mRNA | CTD | PMID:26272509 | TAF5L | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | TAF5L | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of TAF5L mRNA | CTD | PMID:21632981 | TAF5L | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | TAF5L | Human | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of TAF5L mRNA | CTD | PMID:19244175 | TAF5L | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of TAF5L mRNA | CTD | PMID:23806026 | TAF5L | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of TAF5L mRNA | CTD | PMID:38568856 | TAF5L | Human | tamoxifen | affects expression | ISO | Taf5l (Mus musculus) | 6480464 | Tamoxifen affects the expression of TAF5L mRNA | CTD | PMID:17555576 | TAF5L | Human | titanium dioxide | increases methylation | ISO | Taf5l (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of TAF5L gene | CTD | PMID:35295148 | TAF5L | Human | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of TAF5L mRNA | CTD | PMID:34973136 | TAF5L | Human | trimellitic anhydride | increases expression | ISO | Taf5l (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of TAF5L mRNA | CTD | PMID:19042947 | TAF5L | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of TAF5L mRNA | CTD | PMID:37042841 | TAF5L | Human | triptonide | increases expression | ISO | Taf5l (Mus musculus) | 6480464 | triptonide results in increased expression of TAF5L mRNA | CTD | PMID:33045310 | TAF5L | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of TAF5L mRNA | CTD | PMID:25979313 | TAF5L | Human | vinclozolin | decreases expression | ISO | Taf5l1 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of TAF5L mRNA | CTD | PMID:23555832 | TAF5L | Human | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of TAF5L mRNA | CTD | PMID:23649840 | TAF5L | Human | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of TAF5L mRNA | CTD | PMID:19244175 | |